DB:MJJ

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Mani, Inc. engages in the research, development, manufacture, and distribution of medical devices and dental instruments in Japan and internationally.

Rewards

Earnings are forecast to grow 12.8% per year

Risk Analysis

No risks detected for MJJ from our risk checks.


Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

Share Price & News

How has Mani's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MJJ has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-3.5%

MJJ

-8.0%

DE Medical Equipment

-1.6%

DE Market


1 Year Return

2.4%

MJJ

20.5%

DE Medical Equipment

8.3%

DE Market

Return vs Industry: MJJ underperformed the German Medical Equipment industry which returned 21.7% over the past year.

Return vs Market: MJJ underperformed the German Market which returned 3.7% over the past year.


Shareholder returns

MJJIndustryMarket
7 Day-3.5%-8.0%-1.6%
30 Day-4.4%-0.3%0.2%
90 Day9.0%-2.4%12.8%
1 Year3.3%2.4%22.1%20.5%10.7%8.3%
3 Year230.4%218.2%131.5%126.7%3.8%-4.5%
5 Year227.6%207.7%237.6%224.4%9.6%-5.2%

Price Volatility Vs. Market

How volatile is Mani's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Mani undervalued compared to its fair value and its price relative to the market?

70.6x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: MJJ (€21.8) is trading above our estimate of fair value (€11.45)

Significantly Below Fair Value: MJJ is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: MJJ is poor value based on its PE Ratio (70.6x) compared to the DE Medical Equipment industry average (52.3x).

PE vs Market: MJJ is poor value based on its PE Ratio (70.6x) compared to the German market (20.9x).


Price to Earnings Growth Ratio

PEG Ratio: MJJ is poor value based on its PEG Ratio (5.5x)


Price to Book Ratio

PB vs Industry: MJJ is overvalued based on its PB Ratio (7.5x) compared to the DE Medical Equipment industry average (5x).


Next Steps

Future Growth

How is Mani forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

12.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MJJ's forecast earnings growth (12.8% per year) is above the savings rate (0.2%).

Earnings vs Market: MJJ's earnings (12.8% per year) are forecast to grow slower than the German market (23.3% per year).

High Growth Earnings: MJJ's earnings are forecast to grow, but not significantly.

Revenue vs Market: MJJ's revenue (11.5% per year) is forecast to grow faster than the German market (5.8% per year).

High Growth Revenue: MJJ's revenue (11.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MJJ's Return on Equity is forecast to be low in 3 years time (12.6%).


Next Steps

Past Performance

How has Mani performed over the past 5 years?

13.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MJJ has high quality earnings.

Growing Profit Margin: MJJ's current net profit margins (23.4%) are lower than last year (32.6%).


Past Earnings Growth Analysis

Earnings Trend: MJJ's earnings have grown by 13.8% per year over the past 5 years.

Accelerating Growth: MJJ's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MJJ had negative earnings growth (-37.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (0.9%).


Return on Equity

High ROE: MJJ's Return on Equity (10.6%) is considered low.


Next Steps

Financial Health

How is Mani's financial position?


Financial Position Analysis

Short Term Liabilities: MJJ's short term assets (¥25.5B) exceed its short term liabilities (¥2.1B).

Long Term Liabilities: MJJ's short term assets (¥25.5B) exceed its long term liabilities (¥908.0M).


Debt to Equity History and Analysis

Debt Level: MJJ is debt free.

Reducing Debt: MJJ has not had any debt for past 5 years.

Debt Coverage: MJJ has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: MJJ has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Mani current dividend yield, its reliability and sustainability?

0.80%

Current Dividend Yield


Upcoming Dividend Payment


Dividend Yield vs Market

Notable Dividend: MJJ's dividend (0.8%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.25%).

High Dividend: MJJ's dividend (0.8%) is low compared to the top 25% of dividend payers in the German market (3.83%).


Stability and Growth of Payments

Stable Dividend: MJJ's dividends per share have been stable in the past 10 years.

Growing Dividend: MJJ's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (47.8%), MJJ's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Toshihide Takai (68 yo)

no data

Tenure

Mr. Toshihide Takai has been Chief Executive Officer, Representative Executive President and Chief Operating Officer at Mani, Inc. since November 2013 and served as its Managing Director. Mr. Takai has bee ...


Leadership Team

NamePositionTenureCompensationOwnership
Masaaki Matsutani
Executive Chairman6.75yrsno data2.54%
¥ 55.2m
Toshihide Takai
MD, Presidentno datano data0.049%
¥ 1.1m
Kazuo Takahashi
Senior VP6.58yrsno data0.025%
¥ 544.0k
Eiichi Murata
Executive Officer3.58yrsno data0.0052%
¥ 112.8k
Toshiyuki Takase
Senior VP3.92yrsno data0.057%
¥ 1.2m
Masahiko Saito
Chief Manufacturing Officer5.75yrsno data0.017%
¥ 371.6k
Kenji Yone
Executive Officer3.92yrsno datano data
Teruo Takahashi
Executive Officer & Deputy GM of Sales Division5.75yrsno data0.044%
¥ 955.5k

4.8yrs

Average Tenure

61.5yo

Average Age

Experienced Management: MJJ's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Masaaki Matsutani
Executive Chairman6.75yrsno data2.54%
¥ 55.2m
Toshihide Takai
MD, Presidentno datano data0.049%
¥ 1.1m
Kiyoshi Sakai
Independent External Director6.75yrsno data0.00061%
¥ 13.3k
Kanji Matsutani
Chairman of the Board15.75yrsJP¥113.51m3.1%
¥ 67.5m
Tomoko Masaki
Independent External Director5.75yrsno data0.00030%
¥ 6.5k

6.8yrs

Average Tenure

68yo

Average Age

Experienced Board: MJJ's board of directors are considered experienced (6.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Mani, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Mani, Inc.
  • Ticker: MJJ
  • Exchange: DB
  • Founded: 1956
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: JP¥271.460b
  • Listing Market Cap: JP¥2.177b
  • Shares outstanding: 98.43m
  • Website: https://www.mani.co.jp

Number of Employees


Location

  • Mani, Inc.
  • 8-3 Kiyohara Industrial Park
  • Utsunomiya
  • Tochigi
  • 321-3231
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7730TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYJun 2001
MJJDB (Deutsche Boerse AG)YesCommon SharesDEEURJun 2001

Biography

Mani, Inc. engages in the research, development, manufacture, and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as manip ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/03 21:24
End of Day Share Price2020/08/03 00:00
Earnings2020/05/31
Annual Earnings2019/08/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.